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Abstract
Background: This study aims to compare the performance of the recently developed Chinese (city) tariff of the EQ-
5D-3L against the UK, US, Japanese and Korean tariffs in a general rural population in China.
Methods: From November 2015 to September 2016, 12,085 permanent residents aged 45–69 from 257 villages
randomly selected from Hua County, Henan Province, China, were interviewed using EQ-5D-3L, and a one-on-one
questionnaire investigation was used to collect data on factors associated with HRQOL. The health utility scores
were calculated using the UK, US, Japanese, Korean and Chinese (city) tariffs. The agreement, known-groups validity
and sensitivity of these five tariffs were evaluated. Transition scores for pairs of observed EQ-5D-3L health states
were calculated and compared.
Results: The Korean tariff yielded the highest mean health utility score (0.963), followed by the Chinese (city)
(0.948), US (0.943), UK (0.930) and Japanese (0.921) tariffs, but the differences in the scores of any two tariffs did not
exceed the MCID. The Chinese (city) tariff showed higher ICC values (ICCs> 0.89, 95% CI:0.755–0.964) and narrower
limits of agreement (0.099–0.167) than the Korean tariff [(ICCs> 0.71, 95% CI:0.451–0.955); (0.146–0.253)]. The Chinese
(city) tariff had a higher relative efficiency and effect size statistics in 10 out of 11 variables as compared to the UK,
US and Japanese tariffs. The Chinese (city) tariff (0.215) was associated with moderate mean absolute transition
scores compared with the UK (0.342), US (0.230), Japanese (0.149) and Korean (0.189) tariffs for 1485 observed pairs
of the EQ-5D-3L health states.
Conclusions: Health utility scores derived from the five tariffs differed. The Chinese (city) tariff was the most
suitable of these tariffs and was without obvious weakness. We recommend adopting the Chinese (city) tariff when
applying EQ-5D-3L to assess quality of life among the elderly in China’s agricultural region with socio-economic
status similar to Hua County. Results of this study had provided a crucial basis for health surveys, health promotion
projects, health intervention trials, and health economic evaluation taking HRQOL as a target in rural areas of China.
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Background
Measures of health related quality of life (HRQOL) have
become increasingly important in evaluating outcomes of
health-care programs [1]. Among generic instruments of
HRQOL, the three-level European quality of life five-
dimension (EQ-5D-3L) scale is a widely applied
preference-based outcome measure worldwide, as it is
simple, easy to apply and yields high response rates [2].
The validity and reliability of the EQ-5D-3L scale has been
tested in China [3], and has been recommended as a tool
for health technology assessment in China in the publica-
tion “China Guidelines for Pharmacoeconomic Evaluations
and Manual 2015” [2]. Its descriptive system classifies a
health state into three levels (no problem, some/moderate
problems, severe/extreme problems) on five dimensions:
mobility, self-care, usual activities, pain/discomfort and
anxiety/depression, resulting in 243 possible health states.
Each health state can be converted into health utility
scores with tariffs derived primarily from samples of the
general public, patients or healthcare providers. Health
utility scores represent an individual’s overall health status,
and generally range from 0.0 (death) to 1.0 (perfect
health). Some very poor health states, such as a persistent
vegetative state, may be represented by health utility
scores below 0.0 [4].
Evidence has shown that factors such as political sys-
tems, social culture and economic growth may affect the
utility values of EQ-5D-3L health states [5, 6], so peo-
ple’s evaluation on same health problems varied from
different counties. For example, anxiety/depression
problems had different effects on people from countries
with different economic levels. The utility scores for
health state “11,112” (moderate problems in anxiety/de-
pression dimension) were 0.875 and 0.785 respectively in
the perspective of Chinese urban population [7] and Jap-
anese population [8]. Therefore, the choice of tariff may
lead to different cost-utility results and affect decision-
making [6]. It had commonly been suggested that adopt-
ing a population-specific tariff would better reflect the
health preferences of the target population [5]. Before a
China-specific tariff was available, tariffs derived from
the United Kingdom (UK), the United States (US), Japan
and Korea were recommended for use in China, and the
Japanese and Korean tariffs were the best of these due to
geographic proximity and cultural similarities [2]. Liu
et al. developed Chinese utility values for EQ-5D-3L
health states in 2014 based on a population-based sam-
ple drawn from developed cities including Beijing,
Guangzhou, Shenyang, Nanjing and Chengdu [7]. China,
however, is a traditional agricultural country. By the end
of 2017, up to 42.65% of the Chinese population still
lived in rural areas in the context of rapid urbanization.
The Chinese central government implemented a series
of health promotion projects, health surveys and health
intervention trials in rural populations over the course of
the 13th five-year plan [9] and it was essential to accur-
ately measure HRQOL in rural populations for these
health-care programs. At present, China has not devel-
oped a tariff from rural populations. In view of the socio-
economic differences in urban and rural areas [9, 10], it is
unclear whether the health preferences of urban residents
can be applied to measure the HRQOL in rural popula-
tions in China, and this warrants rigorous evaluation. The
previous studies on psychometric properties of HRQOL
derived from the UK, US, Japanese, Korean and Chinese
(city) tariffs were mainly limited to patient populations in
China [11, 12], and only one study in general populations
on the UK, US, Korean and Chinese (city) tariffs was con-
ducted in urban China [13]. No specific evaluation was
carried out in general rural populations in China.
In this study, we aimed to evaluate all potentially ap-
propriate tariffs derived from the UK, US, Japan, Korea
and China (city) in over 12,000 rural adults aged 45–69
on the basis of a large randomized controlled trial in
rural China [14]. Findings will provide fundamental evi-
dence for selection of an appropriate tariff for HRQOL
assessment and health economic evaluation in rural
China.
Methods
Study subjects
Hua County is an agricultural region in the northern
part of Henan Province, China. It is a typical rural area
with a rural population of approximately 954,000, which
accounts for 68.9% of the total population of the county.
The per capita Gross Domestic Product (GDP) of this
area was $2627 in 2017 [9].
In January 2012, we initiated the Endoscopic Screening
for Esophageal Cancer in China (ESECC) randomized
controlled trial (Clinical trial: NCT01688908) in Hua
County to evaluate the efficacy and cost-effectiveness of
population level endoscopic screening for esophageal
squamous cell carcinoma. The inclusion criteria in the
ESECC trial were: 1) permanent residency in a target vil-
lage; 2) age 45–69 (with > 5 years of life expectancy) and
no history of endoscopic examination within 5 years
prior to the initial interview; 3) no history of cancer or
mental disorder; 4) negative for hepatitis B virus, hepa-
titis C virus and human immunodeficiency virus; 5)
agreement to complete all phases of the trial. There are
a total of 968 villages in rural Hua County, and 668 tar-
get villages were randomly selected from the 846 villages
with population sizes ranging from 500 to 3000 in Hua
County [14].
From November 2015 to September 2016, we investi-
gated 12,085 residents aged 45–69 from 257 target vil-
lages of the ESECC trial for the current study.
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Data collection
Enrollment work was carried out in villages, and village
doctors were responsible for notifying potential partici-
pants. A special computer program aided one-on-one
questionnaire investigation was conducted face to face
by investigators well-trained in this interview to investi-
gate potential factors associated with HRQOL. The study
questionnaire elicited background information associ-
ated with HRQOL, such as demographic factors (age,
gender), socio-economic status (educational level, job
type and annual household per capita income), living
conditions (marital status, living arrangement), dietary
habits (frequency of eating fruits and vegetables), health
conditions [body mass index (BMI) and chronic dis-
eases], followed by the EQ-5D-3L scale.
Statistical analysis
We converted EQ-5D-3L scale responses into health
utility scores using the UK [15], US [16], Japanese [8],
Korean [17] and Chinese (city) [7] tariffs. One-way ana-
lysis of variance (ANOVA) with post-hoc Bonferroni
tests (0.001/10) was used to examine the statistical sig-
nificance of the mean derived from the five tariffs. A
minimal clinically important difference (MCID) was de-
fined as a difference of at least 0.074 in the EQ-5D-3L
tariffs, and this MCID was estimated in a study which
used the UK tariff and participant data from eight pub-
lished longitudinal studies [18].
The level of agreement in the health utility scores de-
rived from the UK, US, Japanese, Chinese (city) and Ko-
rean tariffs was assessed by intraclass correlations
coefficients (ICCs) [19] and Bland-Altman plots [20].
The ICCs were calculated using two-way random effect
models with absolute agreement to examine the extent
to which these five tariffs produced the same utility
scores. Agreement was considered poor for ICC values
less than 0.40, fair for values between 0.40 and 0.59,
good for values between 0.60 and 0.74, and excellent for
values between 0.75 and 1.0 [19]. Bland-Altman plots
were used to graphically depict individual-level differ-
ences in the five tariffs [20]. Bland-Altman plots showed
95% limits of agreement, which encompassed 95% of the
individual-level differences in our sample. Narrow limits
reflected smaller differences between any two of the five
tariffs. The mean of the differences (d) and the limits of
agreement (95% CI of d) were indicated by lines in the
Bland-Altman plots. To assess the significance of these
differences, we counted the number of participants for
whom the difference exceeded the MCID.
Known-groups validity was used to evaluate whether
the five tariffs had the ability to discriminate subjects
from known-subgroups with different health status.
Prior to estimating known-groups validity of the five tar-
iffs, we first used the Chi-square test to examine whether
the proportion of full health was significantly different in
subgroups by age, gender, educational level, job type, an-
nual household per capita income, marital status, living
arrangement, frequency of eating fruits and vegetables,
BMI and chronic diseases. The independent t-test was
used to identify whether the mean difference in health
utility scores derived from the five tariffs had the ability
to discriminate all known-subgroups with different
health status.
The sensitivity of these five tariffs was estimated with
the relative efficiency (RE) statistic and Cohen’s d effect
size (ES) statistic [21]. The RE statistic was used to com-
pare the sensitivity of these five tariffs for discriminating
among known-subgroups, which was calculated as the ra-
tio of the Z statistic for the UK, US, Japanese and Korean
tariffs divided by the Z statistic for the Chinese (city) tariff.
The Mann-Whitney test was used to calculate the Z statis-
tic. The ES statistic was computed as the differences in
the mean of known-subgroups divided by the pooled
standard deviation, and effect sizes of 0.2, 0.5, 0.8 indi-
cated small, medium, and large differences respectively.
In addition, we assessed the performance of these tar-
iffs in term of health transition scores for observed pairs
of EQ-5D-3L health states. We measured the absolute
mean transition score in EQ-5D-3L tariffs for observed
pairs of EQ-5D-3L health states. These absolute transi-
tion scores measure the health utility gained for a transi-
tion from a worse health state to a better health state
[6]. These absolute transition scores from the five tariffs
were compared using one-way ANOVA with post-hoc
Bonferroni tests (0.001/10). The consistency of the five
tariffs in predicting positive (health gain) or negative
(health loss) transition scores for observed pairs of EQ-
5D-3L health states was assessed based on Chinese (city)
tariff. Responsiveness of the five tariffs to these consist-
ent health transitions was assessed using standardized
response mean (SRM). SRM was calculated as the post-
treatment mean minus the baseline mean and divided by
the standard deviation of the changed scores between
baseline and post-treatment [6]. In addition, to assess
clinical importance of the differences between transition
scores by different tariffs, we computed the absolute
mean differences of transition scores between China
(city) and four other tariffs and compared them with the
MCID of EQ-5D-3L.
As a result of rigorous logical checking of our system
of investigation, there were few missing data in the vari-
ables from the questionnaire. The annual household per
capita income, living arrangement and BMI variables
were not available for 1002 (8.29%), 3 (0.02%) and 41
(0.34%) subjects respectively, and these subjects were ex-
cluded from analysis.
All statistical analyses were performed using STATA
version 15.0 (STATA Corporation, College Station, TX,
Wang et al. Health and Quality of Life Outcomes          (2020) 18:228 Page 3 of 10
USA). All tests were two-sided and had a significance
level of 0.001.
Results
From 2015 to 2016, a total of 12,085 permanent resi-
dents from rural Hua County were enrolled in this
study. As shown in Table 1, 30.62% of the participants
reported health problems, and lower health status was
associated with older age, female gender, lower levels of
education, working a labor job, lower annual household
per capita income, being unmarried, living alone, low in-
take of fruits and vegetables, obesity, and affliction with
chronic disease.
The mean (95% CI) for Korean, Chinese (city), US, UK
and Japanese health utility scores were 0.963 (0.962–
0.965), 0.948 (0.946–0.950), 0.943 (0.941–0.944), 0.930
(0.927–0.932) and 0.921 (0.919–0.924) respectively
(Table 2). The difference in health utility scores esti-
mated based on the five tariffs was statistically significant
(F = 328.61, p < 0.001). The mean difference (95% CI)
between the Chinese (city) and four other tariffs were as
follows: UK 0.019 (0.018–0.019), US 0.005 (0.005–
0.006), Japan 0.027 (0.026–0.027), and Korea − 0.015
-(0.015–0.016) (Supplement Table 1). Differences in
scores between any two tariffs were statistically signifi-
cant (all p < 0.0001), but the absolute mean difference
did not exceed the MCID.
As shown in Table 3, any two of these five tariffs had
excellent agreement (ICCs> 0.89, 95% CI:0.755–0.969)
with the exception of the Korean tariff. The Korean tariff
showed poor agreement with the US, UK and Japanese
tariffs and the corresponding ICCs were lower than
other ICCs [0.860 (95% CI:0.734–0.915); 0.758 (95% CI:
0.570–0.848); 0.715 (95% CI:0.451–0.831)].
Bland-Altman plots for each pair among the five tariffs
are shown in Supplement Figure 1. Systematic variation
was observed with a decreasing trend in the absolute
score differences as average health utility scores in-
creased. More than 92% of the differences in individual
health utility scores fell within 95% limits of agreement
for each pair of the five tariffs, while the Chinese (city)
and other tariffs (0.099–0.167) had significantly narrower
limits of agreements than the Korean and other tariffs
(0.146–0.253). Moreover, we compared the absolute in-
dividual score differences of any two tariffs with a MCID
of 0.074. 26.97% (3259/12,085), 0.53% (64/12,085), 2.52%
(305/12,085), and 4.74% (573/12,085) of the absolute
score differences in the Chinese (city) and the Japanese,
UK, US, Korean tariffs exceeded the MCID. 30.13%
(3641/12,085), 25.73% (3110/12,085), and 18.12% (2190/
12,085) of the absolute score differences in the Korean
and the Japanese, UK, US tariffs exceeded the MCID,
and in almost all these cases, the Korean scores were
higher than the Japanese, UK and US scores. In the
Table 1 Selected demographic and behavioral characteristics in
12,085 residents from rural Hua County, China
Variable N (%) Full health a
(%)
p value b
Age (years)
45–54 5891 (48.75) 71.46 < 0.001
55–69 6194 (51.25) 67.39
Gender
Male 5913 (48.93) 73.33 < 0.001
Female 6172 (51.07) 65.59
Educational level
Middle School and
above (>6y)
5610 (46.42) 71.76 < 0.001
Primary School and
below (≤6y)
6475 (53.58) 67.31
Job type
Office 214 (1.77) 75.23 < 0.001
Labor 11,871 (98.23) 69.27
Annual household per capita income c
> 2000RMB 5579 (46.16) 70.84 < 0.001
≤ 2000RMB 5504 (45.54) 67.08
Unknown 1002 (8.29) d 73.85
Marital status
Married 11,443 (94.69) 69.69 < 0.001
Unmarried 642 (5.31) 63.71
Living arrangement
Living with spouse
or relatives
11,779 (97.47) 69.73 < 0.001
Living alone 303 (2.51) 55.45
Unknown 3 (0.02) 100.00
Frequency of eating fruits
> 3 times/week 5983 (49.51) 71.92 < 0.001
≤ 3 times/week 6102 (50.49) 66.88
Frequency of eating vegetables
> 3 times/week 11,028 (91.25) 70.29 < 0.001
≤ 3 times/week 1057 (8.75) 59.79
Body mass index
< 30 kg/m2 10,569 (87.46) 70.11 < 0.001
≥ 30 kg/m2 1475 (12.21) 64.14
Unknown 41 (0.34) 68.29
Chronic diseases
No 10,181 (84.24) 71.81 < 0.001
Yes 1904 (15.76) 56.36
Total 12,085 (100) 69.38
a Proportion of respondents reporting no problem in any EQ-5D-3L dimension
b p values were derived from the Chi-square test on full health
c Annual household per capita income is in RMB
d The 1002 subjects excluded due to missing value on annual household per
capita income had better better health status compared to those with no
missing values (p < 0.001)
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other pair wise comparisons of two tariffs, the propor-
tions of absolute score differences that exceeded the
MCID were less than 10%.
Table 4 shows the discriminative ability of the five tar-
iffs for the factors associated with HRQOL, as listed in
Table 1. The EQ-5D-3L scores derived from these five
tariffs were significantly different for all the known-
groups (p < 0.001) except the job type variable, but all of
the absolute mean differences by each of the five tariffs
were lower than the MCID. The RE statistics of the UK,
US and Japanese tariffs were smaller than the Korean
and Chinese (city) tariffs in 10 out of 11 variables, and
the Chinese (city) tariffs were the most efficient in dis-
criminating the differences in age, job type, living ar-
rangement and BMI variables. The ES statistics of the
UK, US and Japanese tariffs were slightly smaller than
the Korean and Chinese (city) tariffs in 10 out of 11 vari-
ables, indicating the UK, US and Japanese tariffs had lower
sensitivity than the Korean and Chinese (city) tariffs. Be-
sides, the ES estimates from the Chinese (city) tariff were
the largest in groups related to two variables and the sec-
ond largest in groups related to nine variables as well.
Fifty-five of the total 243 possible EQ-5D-3L health
states were observed in our study sample. The 55
observed health states resulted in 1485 pairs of health
states (C255). One-way ANOVA and post-hoc Bonferroni
tests showed that the Chinese (city) tariff (0.215) gener-
ally led to lower mean absolute transition scores than
the Western tariffs (the UK:0.342, the US:0.230) and
higher mean absolute transition scores than Asian tariffs
(Japan:0.149, Korea:0.189). In 1163 of 1485 (78.32%)
pairs of the EQ-5D-3L health states, the five tariffs were
consistent in predicting health gain/loss regardless of the
magnitude of the gain/loss. The Chinese (city) tariff had
the lowest and the highest consistency with the UK
(88.66%) and Japanese (93.72%) tariffs. For these consist-
ent health transitions, SRM ranged from 0.79 to 1.08
with the lowest values for the UK and Chinese (city) tar-
iffs. A substantial proportion of differences in transition
scores between Chinese (city) and other tariffs were clin-
ically important (81.93%–88.38% difference in transition
scores >MCID) (Table 5).
Discussion
The EQ-5D-3L scale is recommended for use in health
services decision making, and for quantifying quality ad-
justed life years (QALYs) in cost-utility analysis by a
number of Health Technology Assessment bodies [2]. In
China, it has also been adopted for population health
surveys [9, 10], clinical trials [14] and population-level
screening studies [22] for over 20 years. However, it was
as yet unclear which of the five published tariffs would
be the most suitable for application in rural Chinese
populations. To our knowledge, this was the first study
providing evidence about the performance of the UK,
US, Japanese, Korean and Chinese (city) tariffs for the
EQ-5D-3L scale in a general rural population in China.
Compared to the UK, US, Japanese and Korean tariffs,
the Chinese (city) tariff was found to provide a better
level of agreement, known-groups validity and sensitivity
to reflect the discrepancy between varied levels of
HRQOL related factors, and the performance of ob-
served health transitions revealed that the Chinese (city)
tariff would lead to moderate changes in QALYs for this
rural population.
This study indeed found statistically significant differ-
ences in scores between any two of the five tariffs, and
this was similar to findings in previous studies [5, 6, 13].
In addition to variations in the valuation protocol and
method used for developing varied tariffs, inherent dif-
ferences in populations may be a potential explanation
for the observed differences among different tariffs, in-
cluding cultural norms, population characteristics, state
of health, values, belief, clinical practice and access to
health care services, etc. Given that use of different tar-
iffs may yield different utility scores and cost-utility re-
sults, evaluation of the performance of these five tariffs
among rural populations in China is warranted.
Table 2 The health utility scores derived from the five EQ-5D-3L
tariffs in 12,085 residents from rural Hua County, China
Tariffs a Mean 95% CI SD b Median IQR c Min Max
Korea 0.963 0.962–0.965 0.06 1 0.087 0.151 1
China 0.948 0.946–0.950 0.09 1 0.131 −0.002 1
US 0.943 0.941–0.944 0.09 1 0.173 0.083 1
UK 0.930 0.927–0.932 0.12 1 0.204 −0.349 1
Japan 0.921 0.919–0.924 0.12 1 0.232 0.232 1
a The health utility scores derived from the five tariffs was statistically
significant (F = 328.61, p < 0.0001)
b Standard deviation
c Interquartile range
Table 3 The ICCs derived from the five EQ-5D-3L tariffs in
12,085 residents from rural Hua County, China
ICC (95%CI) a
China/US 0.959 (0.954–0.964)
China/Korea 0.922 (0.836–0.955)
China/UK 0.919 (0.859–0.947)
China/Japan 0.892 (0.755–0.941)
UK/Japan 0.960 (0.953–0.965)
UK/US 0.954 (0.925–0.969)
US/Japan 0.922 (0.838–0.955)
Korea/US 0.860 (0.734–0.915)
Korea/UK 0.758 (0.570–0.848)
Korea/Japan 0.715 (0.451–0.831)
a All p values < 0.0001
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Table 4 Known-groups validity derived from the five EQ-5D-3L tariffs in 12,085 residents from rural Hua County, China
Variable a Tariffs
China UK US Japan Korea
Age (years)
45–55 Mean (Median) 0.954 (1) 0.936 (1) 0.948 (1) 0.928 (1) 0.968 (1)
56–69 Mean (Median) 0.942 (1) 0.923 (1) 0.938 (1) 0.915 (1) 0.959 (1)
Difference 0.012 0.013 0.010 0.013 0.009
Z statistic 6.077 5.519 5.497 5.789 5.639
Relative efficiency 1.000 0.908 0.905 0.953 0.928
Effect size 0.130 0.111 0.104 0.112 0.141
Gender
Male Mean (Median) 0.956 (1) 0.939 (1) 0.951 (1) 0.932 (1) 0.969 (1)
Female Mean (Median) 0.941 (1) 0.920 (1) 0.935 (1) 0.911 (1) 0.959 (1)
Difference 0.015 0.019 0.016 0.021 0.010
Z statistic 8.976 9.382 9.353 9.208 9.747
Relative efficiency 1.000 1.045 1.042 1.026 1.086
Effect size 0.170 0.165 0.169 0.174 0.157
Educational level
Middle School and above(>6y) Mean (Median) 0.954 (1) 0.937 (1) 0.948 (1) 0.929 (1) 0.968 (1)
Primary School and below(≤6y) Mean (Median) 0.943 (1) 0.923 (1) 0.938 (1) 0.915 (1) 0.960 (1)
Difference 0.011 0.014 0.010 0.014 0.008
Z statistic 6.005 5.923 5.889 5.978 6.097
Relative efficiency 1.000 0.986 0.981 0.996 1.015
Effect size 0.126 0.115 0.109 0.115 0.128
Job type
Office Mean (Median) 0.963 (1) 0.947 (1) 0.956 (1) 0.939 (1) 0.975 (1)
Labor Mean (Median) 0.948 (1) 0.929 (1) 0.942 (1) 0.921 (1) 0.963 (1)
Difference 0.015 b 0.018 c 0.014 d 0.018 e 0.012 f
Z statistic 2.208 1.938 1.933 1.967 2.198
Relative efficiency 1.000 0.878 0.875 0.891 0.995
Effect size 0.168 0.151 0.151 0.150 0.176
Annual household per capita income g
> 2000RMB Mean (Median) 0.953 (1) 0.935 (1) 0.947 (1) 0.927 (1) 0.968 (1)
≤ 2000RMB Mean (Median) 0.942 (1) 0.923 (1) 0.938 (1) 0.914 (1) 0.959 (1)
Difference 0.011 0.012 0.009 0.013 0.009
Z statistic 5.250 4.838 4.825 5.054 5.361
Relative efficiency 1.000 0.922 0.919 0.963 1.021
Effect size 0.130 0.104 0.098 0.107 0.138
Marital status
Being married Mean (Median) 0.949 (1) 0.931 (1) 0.943 (1) 0.922 (1) 0.964 (1)
Unmarried Mean (Median) 0.931 (1) 0.911 (1) 0.928 (1) 0.902 (1) 0.951 (1)
Difference 0.018 0.020 0.015 0.020 0.013
Z statistic 3.824 3.675 3.650 3.654 4.042
Relative efficiency 1.000 0.961 0.954 0.956 1.057
Effect size 0.203 0.169 0.165 0.167 0.201
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Table 4 Known-groups validity derived from the five EQ-5D-3L tariffs in 12,085 residents from rural Hua County, China (Continued)
Variable a Tariffs
China UK US Japan Korea
Living arrangement h
Living only with spouse or relatives Mean (Median) 0.949 (1) 0.931 (1) 0.943 (1) 0.922 (1) 0.964 (1)
Living alone Mean (Median) 0.914 (1) 0.889 (1) 0.912 (1) 0.879 (1) 0.940 (1)
Difference 0.035 0.042 0.031 0.043 0.024
Z statistic 6.046 5.881 5.894 5.882 5.913
Relative efficiency 1.000 0.973 0.975 0.973 0.978
Effect size 0.400 0.351 0.345 0.361 0.382
Frequency of eating fruits
> 3 times/week Mean (Median) 0.956 (1) 0.938 (1) 0.949 (1) 0.930 (1) 0.970 (1)
≤ 3 times/week Mean (Median) 0.940 (1) 0.921 (1) 0.937 (1) 0.913 (1) 0.957 (1)
Difference 0.016 0.017 0.012 0.017 0.013
Z statistic 7.607 6.979 6.952 7.149 8.227
Relative efficiency 1.000 0.917 0.914 0.940 1.082
Effect size 0.183 0.139 0.131 0.147 0.195
Frequency of eating vegetables
> 3 times/week Mean (Median) 0.950 (1) 0.932 (1) 0.945 (1) 0.924 (1) 0.965 (1)
≤ 3 times/week Mean (Median) 0.926 (1) 0.904 (1) 0.923 (1) 0.893 (1) 0.947 (1)
Difference 0.024 0.028 0.022 0.031 0.018
Z statistic 7.687 7.527 7.525 7.543 8.159
Relative efficiency 1.000 0.979 0.979 0.981 1.061
Effect size 0.277 0.235 0.236 0.257 0.280
Body mass index i
< 30 kg/m2 Mean (Median) 0.950 (1) 0.932 (1) 0.944 (1) 0.924 (1) 0.965 (1)
≥ 30 kg/m2 Mean (Median) 0.935 (1) 0.913 (1) 0.931 (1) 0.905 (1) 0.954 (1)
Difference 0.015 0.019 0.013 0.019 0.011
Z statistic 5.377 5.098 5.069 5.219 5.167
Relative efficiency 1.000 0.948 0.943 0.971 0.961
Effect size 0.166 0.157 0.148 0.154 0.175
Chronic diseases
No Mean (Median) 0.954 (1) 0.936 (1) 0.948 (1) 0.929 (1) 0.968 (1)
Yes Mean (Median) 0.918 (1) 0.893 (1) 0.914 (1) 0.883 (1) 0.941 (1)
Difference 0.036 0.043 0.034 0.046 0.027
Z statistic 14.704 14.103 14.095 14.300 14.809
Relative efficiency 1.000 0.959 0.959 0.973 1.007
Effect size 0.403 0.372 0.369 0.378 0.413
a All difference scores were statistically significant using the independent t-test except for the job type variable, p < 0.001
b p = 0.0151
c p = 0.0283
d p = 0.0285
e p = 0.0301
f p = 0.0107
g Annual household per capita income was not available for 1002 (8.29%) subjects, who were excluded from analysis
h Living arrangement was not available for 3 (0.02%) subjects, who were excluded from analysis
i Body mass index was not available for 41 (0.34%) subjects, who were excluded from analysis
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In this study, we assessed the performance of the five
tariffs based on level of agreement, known-groups valid-
ity and sensitivity for reflecting the discrepancy between
varied levels of HRQOL related factors in this rural
population. The Korean tariff had the lowest level of
agreement with other tariffs compared with the level of
agreement among four other tariffs, and was in disagree-
ment with the UK, US and Japanese tariffs regarding
what constituted “good” and “bad” health states. More-
over, Bland-Altman plots demonstrated the possibility
that the Korean tariff systematically valued same health
states higher than other tariffs do. These findings dif-
fered from a community-based study in Shenzhen,
China, which investigated over 3028 inhabitants aged 15
and older and reported excellent agreement among the
UK, Japanese, Korean and Chinese (city) tariffs [13]. Pos-
sible explanations for these differences in findings were
as follows. First, the proportion of respondents with
health problems was as high as 30.62% in our study, in
contrast to 7% in the study by Wu et al. [13]. The dis-
crepancy among different tariffs would be smaller for
better health status, but larger for severe health status.
As a result, the level of agreement between the Korean
tariff and other tariffs in this rural population with poor
health status would significantly decrease. Second, pain/
discomfort, which is the most common problem world-
wide with a prevalence ranging from 29.4 to 61.3% [9],
had different effect on the health of individuals in differ-
ent countries, and the effect on health utility scores from
the Korean tariff was the smallest compared to four
other tariffs. For example, the effect of health state “11,
121” valued by the Korean tariff was minimal with a util-
ity value of 0.037, while the effect derived from the UK,
US, Japanese and Chinese (city) tariffs was relatively lar-
ger with utility values of 0.080 to 0.173. Therefore, the
Korean tariff tended to overestimate the actual level of
HRQOL in general rural populations in China, thus de-
creasing its comparability with other tariffs in health
utility scores.
With respect to known-groups validity, the absolute
mean differences in all known-subgroups of each of the
five tariffs were lower than the MCID. This result was
different from previous studies, where the absolute mean
differences in some known-subgroups exceeded the
MCID [6, 13, 23]. The main reason for this difference
was as follows. Compared to populations in previous
studies covering entire adult stage and different educa-
tion levels, subjects in our study were mainly limited to
farmers who were not well educated aged 45–69 years,
and their living conditions had stronger homogeneity,
resulting in a lesser quality of life variation in different
subgroups. Therefore, the absolute mean differences of
these five tariffs in all known-subgroups did not exceed
the MCID. Thus, we further observed that the EQ-5D-
3L tariffs might have limited discriminative ability in this
rural population in China, but the RE and ES statistics
from the UK, US and Japanese tariffs were continuously
lower in 10 out of 11 variables than the statistics from
Korean and Chinese (city) tariffs, which prompted the
view that Western and Japanese tariffs might provide
lower sensitivity than Korean and Chinese (city) tariffs
in this Chinese general rural population. Korea and
China are Asian countries sharing similar cultures and
values, and the Asian tariffs may thus better reflect
health preferences in rural Chinese populations than the
Western tariffs do. These findings were similar to previ-
ous studies which had also found that the Western tar-
iffs had poorer discriminative ability than the Asian
tariffs in Asian populations [13, 23]. The results stressed
the importance of using local tariff instead of inter-
national tariffs in context-specific decision-making pro-
cesses. In addition, the Japanese valuation study was
undertaken more than 17 years ago [8], while Korean
and Chinese (city) valuation studies were conducted in
2009 and 2014 respectively [7, 17]. With socio-economic
development, medical practice patterns, access to health
services and public health status may change as well,
relevant to secular trends in social preferences, which
may lead to a difference in health preferences of more
than a decade ago as compared with the current people’s
understanding of health. This finding shows that health
valuation study will be a long-term undertaking that de-
serves constant attention and timely updating.
Table 5 Absolute transition scores, consistent health transition and standardized response mean for the observed EQ-5D-3L health
transitions in 12,085 residents from rural Hua County, China
Tariffs Absolute mean
transition score
95% CI Consistent health gain/
loss (China vs.) (%)
Standardized response
mean for consistent
transitions (n = 1163)
Clinically important
difference in transition
scores compared with
China (%)
China 0.215 0.21–0.22 – 1.08 –
UK 0.342 0.33–0.36 88.66 0.79 88.38
US 0.230 0.22–0.24 90.96 0.83 81.93
Japan 0.149 0.14–0.16 93.72 1.04 83.12
Korea 0.189 0.18–0.20 89.68 1.02 85.58
Wang et al. Health and Quality of Life Outcomes          (2020) 18:228 Page 8 of 10
The Chinese (city) tariff generally led to smaller
changes than Western tariffs and higher changes than
two other Asian tariffs in QALYs which translated into
less and greater favorable incremental cost-effectiveness
ratios (ICERs). In addition, the Chinese (city) tariff had
smaller values than the Korean tariff and higher values
than the UK, US, and Japanese tariffs. Therefore, com-
pared to the Western tariffs, the Chinese (city) tariff had
higher values attached to impaired health states, which
resulted in higher utility gain from life-extending inter-
ventions and smaller utility gain from quality of life-
improving measures. This implied that application of the
Chinese (city) tariff in place of Western tariffs would re-
sult in more favorable ICERs for life-extending interven-
tions and less favorable ICERs for quality of life-
improving interventions. The findings suggested that
choice of tariff might have important impact on eco-
nomic evaluation studies and funding decisions. It has to
be reiterated that the choice of which tariff to use in em-
pirical studies should be based on specific study ques-
tions and not on how attractive the resulting ICER
might be.
Generally speaking, an appropriate tariff should be
able to not only reflect the actual level of the quality of
life of a population and facilitate comparison with other
health-care evaluation programs (external validity), but
should also be able to fully demonstrate the differences
in various levels of HRQOL related factors in the study
population (internal validity). Based on the analysis
above, the Chinese (city) tariff was the most suitable of
five tariffs under evaluation and showed no obvious
weakness, and would be suitable for use when assessing
HRQOL using EQ-5D-3L in a rural population in China.
The main limitation of this study was that it was a sin-
gle center investigation of residents aged 45–69 and in-
dividuals with severe conditions were not included.
Thus, our results and conclusions should be interpreted
with caution if they are being considered for
generalization to other populations with broader age
ranges and/or individuals with severe medical conditions
involving disability or bedridden illness. As a conse-
quence of cross-sectional design of this study and lack of
data on changes in health status over time, all possible
transitions were treated as if they had the same probabil-
ity of occurrence. However, some theoretical health
states or transitions are less likely to happen in reality.
Conclusions
This study systematically evaluated the performance of
tariffs derived from the UK, US, Japan, Korea and China
(city) in a rural Chinese population based on a large ran-
domized controlled trial in rural China. We recommend
adopting this Chinese (city) tariff when applying EQ-5D-
3L to assess quality of life among the elderly in China’s
agricultural region with socio-economic status similar to
Hua County. Results of this study had provided a crucial
basis for health surveys, health promotion projects,
health intervention trials and health economic evaluation
taking HRQOL as a target in rural areas of China, and
results will also serve as a foundation for cost-utility ana-
lysis in the ESECC trial in the future.
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